Impax Pharmaceuticals: Commercialization & Sales

Committed to improving patient lives through advancing knowledge of treatments for neurological disorders

Since inception in July 2006, Impax Pharmaceuticals' commercial organization has established a leading presence within the neurology community. Impax deploys approximately 120 field personnel determined to further enhance and solidify long standing relationships with over 8,500 neurologists in the US.

Impax has adopted a customer focused orientation towards all commercial interactions. In that relation, we strive to first understand customer informational needs relative to our products and then responsibly offer solutions intended to satisfy that expressed need. This requires a highly competent, educated and well-trained field organization with the presence of mind to appropriately address customer concerns.

Current Products

Treatments for CNS Disorders

Rytary
Zomig

Other Specialty Products

Albenza
Emverm™